![Page 1: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/1.jpg)
Polymyalgia Rheumatica and Giant Cell Arteritis
![Page 2: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/2.jpg)
Definition of Fibromyalga
• “Chronic and widespread pain located at 11 or more of 18 tender points”-ACR definition
• No specific diagnostic test and no cure.
![Page 3: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/3.jpg)
Clinical manifestations
• Chronic and persistent pain with varying manifestations
• Diffuse musculoskeletal pain, stiffness and fatigue• Joints not swollen painful or red• Sensation such as tingling, numbness, burning,
crawling are often described• Pain is aggravated by change in weather, stress,
fatigue, lack of sleep et cetera et cetera
![Page 4: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/4.jpg)
Epidemiology
• 2% of all US citizens affected: 5.5 million• Most common cause of generalized pain in
women ages 20 to 50• Prevalence increases with age: 2% ages 20 to
35, with 8% at age 70• Females 10 times more common than males
![Page 5: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/5.jpg)
.
Source: “The Manual Tender Point Survey”, D. Sinclair, T. Starz, D. Turk Univ. of Pittsburgh, School of Medicine
![Page 6: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/6.jpg)
Tender points
• Usually described with a number of kilos of pressure
• In reality no real guidelines
• 11 of 18 tender points
• Fraught with controversy
![Page 7: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/7.jpg)
: Comorbid conditions
• Irritable bowel syndrome• Chronic fatigue syndrome• Migraine headache syndrome• Sleep disorder• Altered cognitive function• TM problems
![Page 8: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/8.jpg)
Differential diagnosis
• Polymyalgia rheumatica• Dermato or polymyositis• Hypothyroidism• Rheumatoid arthritis• Lyme disease• Toxic myopathies secondary to statin
exposure or fibric acid
![Page 9: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/9.jpg)
Definitions
• Polymyalgia Rheumatica (PMR) – Inflammatory condition of unknown etiology.
• Giant Cell Arteritis (GCA) – Vasculitis of medium or large arteries of unknown cause
• They often occur together so are suspected to have the same underlying pathophysiology.
![Page 10: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/10.jpg)
PMR
• Diagnosis is difficult and uncertain as the symptoms are non-specific. As such incidence is hard to predict.
• Shoulder and/or pelvic girdle pain with early morning stiffness forms the polymyalgic syndrome.
• There is no diagnostic test and is in many ways a diagnosis of exclusion.
![Page 11: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/11.jpg)
Bird Criteria (3 or more)
• Bilateral shoulder pain or stiffness• Onset of illness less than 2 weeks• Initial ESR >40• Morning stiffness >1hr• Age 65 or older• Depression and/or weight loss• Bilateral tenderness in upper arms
![Page 12: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/12.jpg)
PMR
• Take care not to miss other causes of the symptoms
• PMR less likely to be the cause if: incomplete response to steroids, muscular weakness, prominent peripheral joint symptoms, lack of morning stiffness, unilateral symptoms.
• ESR/CRP are usually raised, normochromic normocytic anaemia is common, LFT’s esp AlkP may be abnormal.
![Page 13: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/13.jpg)
PMR
• It’s complications are debility due to pain.• 20% will develop GCA• Response to steroid is rapid though some
patients are hard to wean off steroids.
![Page 14: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/14.jpg)
GCA
• 3 times more common in females• Also known as temporal arteritis• Affects cranial branches of arteries from arch
of aorta and branches of ophthalmic artery.• Associated with critical ischaemia : stroke
blindness.• These can occur very early in the disease.
![Page 15: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/15.jpg)
GCA
• Rare if <50y old• Unilateral headache most often in temporal
region.• Scalp tenderness classically noticed while
brushing hair.• Pain on chewing – claudication of muscles of
mastication• Fever, weight loss, fatigue, anorexia.
![Page 16: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/16.jpg)
GCA
• Double vision or amaurosis fugax (transient painless loss of monocular vision of variable duration)
• Can have reduced visual acuity and/or visual field defects.
• Fundoscopy – oedema/pallor of optic disc small retinal haemorrhages may also be seen
![Page 17: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/17.jpg)
GCA
• Include general CV examination – check BP both arms as aortic dissection can occur.
• Check peripheral pulses and listen for carotid bruits.
• The American College Of Rheumatology (ACR) is a helpful diagnostic criteria.
![Page 18: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/18.jpg)
ACR Criteria for GCA(three or more needed)
• Age 50 or greater• New type of headache• Clinically abnormal temporal artery (thickened,
tender or nodular decreased pulsation)• ESR 50 or >• Abnormal artery biopsy – necrotizing arteritis
with mononuclear infiltrate or granulomatous infiltrate usually with multinucleated giant cells!
![Page 19: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/19.jpg)
GCA
• Inflammatory markers are not always raised do not withhold treatment if strong clinical suspicion.
• As PMR normochromic normocytic anaemia is common as are abnormal LFT’s
• Use of temporal artery biopsy is debated - + confirms GCA but negative does not exclude due to skip lesions
![Page 20: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/20.jpg)
GCA
• Large artery complications common• Aortic aneurysm or dissection occurs in 18%!!!• Patients with GCA have a higher risk of
stroke/MI/CHF.• A variety of neurological complications can
also ensue• Early adequate dose steroids prevent most
complications.
![Page 21: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/21.jpg)
GIANT CELL ARTERITISPresentation
• Headache• Scalp tenderness• Thickened temporal
arteries• Jaw claudication• Acute visual loss• Weight loss, anorexia,
fever, night sweats, malaise & depression
![Page 22: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/22.jpg)
GIANT CELL ARTERITIS Temporal Artery Biopsy
• Arteries have skip lesions• ultrasound/Doppler may
help identify involved areas• If positive, confirms
diagnosis – helpful in management of future disease
• If negative, doesn’t exclude diagnosis, but need to think about an alternative diagnosis
![Page 23: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/23.jpg)
Management of PMR and GCA
• Follows pattern of induction, maintenance and reduction of treatment.
• Most evidence for steroid dose is observational
• Oral prednisolone is the most common treatment used.
![Page 24: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/24.jpg)
Management of PMR and GCA
1) PMR no signs GCA- Prednisolone 10-20mg od (after baseline
investigations)- 70% improve in 1/52- Inflammatory markers improve in 3-4/522) GCA without visual disturbance- 40-60mg prednisolone od- R/V at 48hrs sooner if visual disturbance
![Page 25: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/25.jpg)
Management of PMR and GCA
3) GCA with visual disturbance- Medical emergency 60mg prednisolone urgent
admission to ophthalmologists
![Page 26: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/26.jpg)
Maintenance• PMR and GCA continue dose steroid for up to 4
weeks then can be decreased every 2-4weeks 5mg a time in GCA and 2.5mg in PMR.
• When on 10mg decrease every 4-6weeks by 1mg• When on 7mg maintain at this for 12months
before reducing further.• Steroids should only be stopped if proximal pain
and morning stiffness have resolved.• Helpful to monitor CRP/ESR during above• Can relapse requiring step up in steroid again
![Page 27: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/27.jpg)
Who and when to Refer?
• GCA any with visual symptoms even if on treatment should be referred on that day to ophthalmology.
• Other patients with GCA – routine referral to rheumatology or general medicine for shared care.
• PMR can be managed in GP setting• Consider secondary care referral if doubt as to
diagnosis, poor response to treatment or adverse effects with steroid treatment.
![Page 28: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/28.jpg)
Considerations
• Don’t forget long term risks of steroid treatment especially if used for 12-24+months
• Frequent BP and bloods should be offered • Osteoporos is important consideration• Encourage increased activity
![Page 29: Polymyalgia Rheumatica and Giant Cell Arteritis](https://reader035.vdocument.in/reader035/viewer/2022062217/5681593e550346895dc67d46/html5/thumbnails/29.jpg)
Summary
• PMR – pain+stiffness proximal muscles GCA vasculitis – headaches/scalp tenderness
• GCA vasculitis – headaches/scalp tenderness• GCA can cause irreversible blindness• ESR + CRP are commonly raised in GCA +PMR• Dramatic response to corticosteroids in both• Relapse common during steroid reduction• Patients require long term steroids thus use
osteoporosis prophylaxis as per local guidelines.